Margaret C. Watson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Margaret C. Watson has a total of 205 co-authors. Here are the top co-authors by number of shared publications:
Christine M Bond
University of Aberdeen; Division of Applied Health Sciences; Polwarth Building Foresterhill Aberdeen UK AB25 2ZD
8 shared publicationsChristine M. Bond
Centre of Academic Primary Care, University of Aberdeen, UK
6 shared publications- Jeremy Michael Grimshaw
Clinical Epidemiology Program, Ottawa Health Research Institute, Ottawa, Canada
5 shared publications Marie Johnston
The Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
5 shared publications- Matthew D. Jones
Department of Life Sciences, University of Bath, Bath, UK
5 shared publications David Gillespie
Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, Wales
4 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
Interventions to promote the early detection of cancer in community pharmacies: a systematic review
Objectives: Early detection and diagnosis of cancer is associated with greater treatment success and improved survival. Community pharmacies are often the first point of contact for patients with symptoms that could be due to cancer (e.g. persistent cough, rectal bleeding, dysphagia), and could contribute to earlier cancer detection. Methods: This systematic review assessed the evidence for community pharmacy-based interventions to support the early detection of cancer. Five databases (Medline, EMBASE, HMIC, CINAHL, and PSYCINFO) and other supplementary sources were searched for the time period January 2000–February 2025. Standard systematic review methodology following PRISMA guidelines was used. Independent duplicate screening, study selection, data extraction, and quality assessment were undertaken. Key findings: In total, 27 studies from 10 countries were included. Several cancer types were represented including colorectal (n = 13), lung (n = 4), skin (n = 4), breast (n = 1), prostate (n = 1), breast and cervical (n = 1), gastric (n = 1), colorectal and prostate (n = 1) and one study included multiple cancer types. The interventions included targeted screening (n = 2), population screening (n = 15), triage (n = 8) and health promotion (n = 2). From the 10 studies that reported cancer diagnosis rates, 3274 individuals had cancerous or precancerous lesions detected: colorectal (n = 2816); prostate (n = 14); and skin (n = 453), with a referral conversion rate ranging between 3.4% and 8.5%. Conclusions: Harnessing the expertise of community pharmacy personnel is likely to support patients in an earlier and faster diagnosis of cancer. The integration of community pharmacy into early detection pathways is key to maximizing their potential.
- 18 September 2026
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
Open AccessInterventions to promote the early detection of cancer in community pharmacies: a systematic review
Objectives: Early detection and diagnosis of cancer is associated with greater treatment success and improved survival. Community pharmacies are often the first point of contact for patients with symptoms that could be due to cancer (e.g. persistent cough, rectal bleeding, dysphagia), and could contribute to earlier cancer detection. Methods: This systematic review assessed the evidence for community pharmacy-based interventions to support the early detection of cancer. Five databases (Medline, EMBASE, HMIC, CINAHL, and PSYCINFO) and other supplementary sources were searched for the time period January 2000–February 2025. Standard systematic review methodology following PRISMA guidelines was used. Independent duplicate screening, study selection, data extraction, and quality assessment were undertaken. Key findings: In total, 27 studies from 10 countries were included. Several cancer types were represented including colorectal (n = 13), lung (n = 4), skin (n = 4), breast (n = 1), prostate (n = 1), breast and cervical (n = 1), gastric (n = 1), colorectal and prostate (n = 1) and one study included multiple cancer types. The interventions included targeted screening (n = 2), population screening (n = 15), triage (n = 8) and health promotion (n = 2). From the 10 studies that reported cancer diagnosis rates, 3274 individuals had cancerous or precancerous lesions detected: colorectal (n = 2816); prostate (n = 14); and skin (n = 453), with a referral conversion rate ranging between 3.4% and 8.5%. Conclusions: Harnessing the expertise of community pharmacy personnel is likely to support patients in an earlier and faster diagnosis of cancer. The integration of community pharmacy into early detection pathways is key to maximizing their potential.
- Open Access
Prescribing for older people with sensory impairment: a qualitative interview study with independent prescribers in primary care
Objectives: To explore prescribers’ awareness of medicine-related challenges of older people (≥65 years) with sensory impairment (hearing, visual or dual impaired) and identify the influences on prescribing behaviours for these patient populations. Design: Semistructured interviews were completed online. Setting: Primary care-based prescribers in the UK. Participants: Independent prescribers working in primary care. Participants were recruited through professional networks and organisations, social media and using snowballing. Purposive sampling was used to ensure variation in roles, practice/organisational settings and geographical location. Results: 15 prescribers participated, including general practitioners (n=6), pharmacists (n=5), nurses (n=3) and one optometrist. Many demonstrated limited awareness of sensory impairment and suggested that outdated patient records contribute to it being easy to overlook. Prescribers underestimated sensory impairment prevalence, with one predicting that only a small proportion of older patients had hearing loss. Formal training on prescribing for older people with sensory impairment was minimal, and most relied on experiential learning. Prescribers employed strategies to support safe prescribing, such as simplifying regimens and selecting lower-risk medications. The prescribers also reported a lack of evidence-based guidelines or resources tailored to these patient populations. Conclusions: Prescribers currently receive minimal training to support their prescribing practices for older people with sensory impairment. Given the increasing prevalence of age-related sensory impairment, evidence-based resources and training are needed to support prescribing for these patient populations.
Open AccessPrescribing for older people with sensory impairment: a qualitative interview study with independent prescribers in primary care
Objectives: To explore prescribers’ awareness of medicine-related challenges of older people (≥65 years) with sensory impairment (hearing, visual or dual impaired) and identify the influences on prescribing behaviours for these patient populations. Design: Semistructured interviews were completed online. Setting: Primary care-based prescribers in the UK. Participants: Independent prescribers working in primary care. Participants were recruited through professional networks and organisations, social media and using snowballing. Purposive sampling was used to ensure variation in roles, practice/organisational settings and geographical location. Results: 15 prescribers participated, including general practitioners (n=6), pharmacists (n=5), nurses (n=3) and one optometrist. Many demonstrated limited awareness of sensory impairment and suggested that outdated patient records contribute to it being easy to overlook. Prescribers underestimated sensory impairment prevalence, with one predicting that only a small proportion of older patients had hearing loss. Formal training on prescribing for older people with sensory impairment was minimal, and most relied on experiential learning. Prescribers employed strategies to support safe prescribing, such as simplifying regimens and selecting lower-risk medications. The prescribers also reported a lack of evidence-based guidelines or resources tailored to these patient populations. Conclusions: Prescribers currently receive minimal training to support their prescribing practices for older people with sensory impairment. Given the increasing prevalence of age-related sensory impairment, evidence-based resources and training are needed to support prescribing for these patient populations.
- Open Access
- 25 November 2025
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 26, e96
A scoping review of guidelines and resources to promote evidence based prescribing for older people with sensory impairment
Aim: This review explored whether and how prescribers modify their prescribing behaviour for older people (≥65) with hearing, visual or dual impairment (hereafter referred to as sensory impairment) in primary care settings and identified what evidence sources exist to inform prescribing for these specific patient populations. Background: Older people with sensory impairment may experience substantial challenges with medicines management compared with older people without sensory impairment. The prevalence of sensory impairment and medicine use increases with age, as such, practitioners may need to consider how to modify their prescribing behaviour to improve the safe and effective use of medicines. Methods: This study was conducted to reflect the Joanna Briggs Institute [JBI] methodology for scoping reviews. Electronic databases were searched: MEDLINE (Ovid), EMBASE (Ovid), Cochrane Library, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Google, and Google Scholar. Qualitative and quantitative studies were included if published between January 2012 and April 2023. Grey literature sources, including Google and Google Scholar, were also searched. Studies were eligible for inclusion if they focussed on prescribing behaviour for older people with sensory impairment in primary care settings. Independent duplicate data extraction was undertaken of details about the participants, concept, context, study methods, outcomes, and key findings relevant to the review question. Findings: A total of 3,590 records were identified through database searching and 10 full text articles were retrieved. Grey literature identified a further 61 records. On examination, none of the articles fulfilled the inclusion criteria for this review. Conclusions: This review has highlighted a gap in the evidence regarding prescribing for these high risk patient populations. There may be a need for the development of resources, such as evidence based guidelines, to support the safe and effective use of medicines for these specific patient populations.
- 25 November 2025
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 26, e96
Open AccessA scoping review of guidelines and resources to promote evidence based prescribing for older people with sensory impairment
Aim: This review explored whether and how prescribers modify their prescribing behaviour for older people (≥65) with hearing, visual or dual impairment (hereafter referred to as sensory impairment) in primary care settings and identified what evidence sources exist to inform prescribing for these specific patient populations. Background: Older people with sensory impairment may experience substantial challenges with medicines management compared with older people without sensory impairment. The prevalence of sensory impairment and medicine use increases with age, as such, practitioners may need to consider how to modify their prescribing behaviour to improve the safe and effective use of medicines. Methods: This study was conducted to reflect the Joanna Briggs Institute [JBI] methodology for scoping reviews. Electronic databases were searched: MEDLINE (Ovid), EMBASE (Ovid), Cochrane Library, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Google, and Google Scholar. Qualitative and quantitative studies were included if published between January 2012 and April 2023. Grey literature sources, including Google and Google Scholar, were also searched. Studies were eligible for inclusion if they focussed on prescribing behaviour for older people with sensory impairment in primary care settings. Independent duplicate data extraction was undertaken of details about the participants, concept, context, study methods, outcomes, and key findings relevant to the review question. Findings: A total of 3,590 records were identified through database searching and 10 full text articles were retrieved. Grey literature identified a further 61 records. On examination, none of the articles fulfilled the inclusion criteria for this review. Conclusions: This review has highlighted a gap in the evidence regarding prescribing for these high risk patient populations. There may be a need for the development of resources, such as evidence based guidelines, to support the safe and effective use of medicines for these specific patient populations.
- Open Access
- 20 November 2025
- Published by SAGE Publications in HERD: Health Environments Research & Design Journal
- Vol. 19 (2) , 48-67
A Scoping Review of the Impact of Environmental Design on Wayfinding for People With Sensory Impairment
Purpose: This review aimed to identify the environmental factors impacting wayfinding by people with sensory impairment (SI) and the perceived barriers and facilitators of those factors. In addition, the review explored design recommendations to improve the accessibility of built environments for this population. Background: Wayfinding design is frequently misconceived as the implementation of signage, whereas it also involves spatial planning to facilitate intuitive navigation. Individuals with visual and hearing impairments face multiple accessibility challenges that could be tackled through user-centered design. Methods: A scoping review was conducted using standard methodology. Electronic databases were searched (Medline, Embase, APA PsycINFO, SCOPUS, Web of Science) from January 2000 to August 2023. Independent duplicate screening was performed for 10% of sources. The extracted data was analyzed using content analysis. A conceptual framework was developed to map the key environmental factors impacting the individual's wayfinding with SI. Results: From the 3,716 records identified, 41 studies were included. Results were categorized into three domains of architectural, graphical, and sensory elements. Frequently cited architectural barriers included complex layouts, unclear circulation, nonstandard stairs, and the presence of obstacles. Regarding graphical elements, the nonstandard design or placement of signage was common. Key sensory challenges were related to insufficient lighting, low visual contrast, and the inappropriate selection of materials. Conclusions: This review highlighted multiple environmental factors that influence wayfinding for people with SI. Policymakers, architects, and designers could use these results to eliminate barriers in the built environment and develop evidence-based design interventions addressing the access needs of this population.
- 20 November 2025
- Published by SAGE Publications in HERD: Health Environments Research & Design Journal
- Vol. 19 (2) , 48-67
Open AccessA Scoping Review of the Impact of Environmental Design on Wayfinding for People With Sensory Impairment
Purpose: This review aimed to identify the environmental factors impacting wayfinding by people with sensory impairment (SI) and the perceived barriers and facilitators of those factors. In addition, the review explored design recommendations to improve the accessibility of built environments for this population. Background: Wayfinding design is frequently misconceived as the implementation of signage, whereas it also involves spatial planning to facilitate intuitive navigation. Individuals with visual and hearing impairments face multiple accessibility challenges that could be tackled through user-centered design. Methods: A scoping review was conducted using standard methodology. Electronic databases were searched (Medline, Embase, APA PsycINFO, SCOPUS, Web of Science) from January 2000 to August 2023. Independent duplicate screening was performed for 10% of sources. The extracted data was analyzed using content analysis. A conceptual framework was developed to map the key environmental factors impacting the individual's wayfinding with SI. Results: From the 3,716 records identified, 41 studies were included. Results were categorized into three domains of architectural, graphical, and sensory elements. Frequently cited architectural barriers included complex layouts, unclear circulation, nonstandard stairs, and the presence of obstacles. Regarding graphical elements, the nonstandard design or placement of signage was common. Key sensory challenges were related to insufficient lighting, low visual contrast, and the inappropriate selection of materials. Conclusions: This review highlighted multiple environmental factors that influence wayfinding for people with SI. Policymakers, architects, and designers could use these results to eliminate barriers in the built environment and develop evidence-based design interventions addressing the access needs of this population.
- Open Access
- 15 April 2025
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 33 (2) , 235-240
Prevalence of information- and advice-seeking by patients for newly prescribed medicines and interventions to promote these behaviours: scoping reviews
Objectives: To conduct scoping reviews to assess the prevalence of information- and advice-seeking by patients from pharmacy personnel for newly prescribed medicines, and interventions to promote these behaviours. Methods: Standard scoping review methods were used and reported using the PRISMA-ScR checklist. Searches were conducted of electronic databases: Medline (via Ovid), Embase (via Ovid), Cinahl (via EBSCO host), and PsycINFO. MeSH terms and keywords were used. The inclusion period was 2010–2024. Independent, duplicate screening, data extraction, and quality appraisal was undertaken. Quality assessment was undertaken using validated tools. Key findings: Two studies were identified: prevalence (n = 1) and intervention (n = 1). Information was most frequently sought for dosage information and drug side effects. The intervention study evaluated the feasibility and acceptability of a computer kiosk to provide counselling and medication-related advice. The methodological quality varied from low (prevalence n = 1) to moderate (n = 2). Conclusions: There is paucity of empirical data regarding the extent to which patients engage with information- and advice-seeking and the effectiveness of interventions to promote these behaviours. Knowledge about medicine increases the likelihood of medication adherence and intended health outcomes. This research has identified a knowledge gap in terms of the prevalence of information- and advice-seeking by patients for prescription medicines and the effectiveness of interventions to promote these behaviours. Effective strategies are needed to promote these behaviours to increase adherence and therapeutic benefit, and decrease waste and iatrogenic disease.
- 15 April 2025
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 33 (2) , 235-240
Open AccessPrevalence of information- and advice-seeking by patients for newly prescribed medicines and interventions to promote these behaviours: scoping reviews
Objectives: To conduct scoping reviews to assess the prevalence of information- and advice-seeking by patients from pharmacy personnel for newly prescribed medicines, and interventions to promote these behaviours. Methods: Standard scoping review methods were used and reported using the PRISMA-ScR checklist. Searches were conducted of electronic databases: Medline (via Ovid), Embase (via Ovid), Cinahl (via EBSCO host), and PsycINFO. MeSH terms and keywords were used. The inclusion period was 2010–2024. Independent, duplicate screening, data extraction, and quality appraisal was undertaken. Quality assessment was undertaken using validated tools. Key findings: Two studies were identified: prevalence (n = 1) and intervention (n = 1). Information was most frequently sought for dosage information and drug side effects. The intervention study evaluated the feasibility and acceptability of a computer kiosk to provide counselling and medication-related advice. The methodological quality varied from low (prevalence n = 1) to moderate (n = 2). Conclusions: There is paucity of empirical data regarding the extent to which patients engage with information- and advice-seeking and the effectiveness of interventions to promote these behaviours. Knowledge about medicine increases the likelihood of medication adherence and intended health outcomes. This research has identified a knowledge gap in terms of the prevalence of information- and advice-seeking by patients for prescription medicines and the effectiveness of interventions to promote these behaviours. Effective strategies are needed to promote these behaviours to increase adherence and therapeutic benefit, and decrease waste and iatrogenic disease.
- Open Access
Safety and effectiveness of anticoagulation therapy in older people with atrial fibrillation during exposed and unexposed treatment periods
Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused in older populations due to concerns about bleeding. This study aimed to compare the safety and effectiveness of anticoagulation during periods of exposure and non-exposure and across different anticoagulants in people with AF aged ≥75 years. Methods Using UK primary care data from the Clinical Practice Research Datalink (2013–2017), a retrospective cohort study was conducted on patients newly prescribed oral anticoagulants (warfarin or direct oral anticoagulants). Exposure to anticoagulation was mapped using prescription data. Cox regression models were used to estimate adjusted HRs for stroke, bleeding, myocardial infarction, and death during periods of exposure and non-exposure and for different anticoagulants. Results Among 20 167 patients (median age 81 years), non-exposure to anticoagulation was associated with higher risks of stroke (HR 3.07, 95% CI 2.39 to 3.93), myocardial infarction (HR 1.85, 95% CI 1.34 to 2.56) and death (HR 2.87, 95% CI 2.63 to 3.12) compared with exposure. Compared with warfarin, apixaban was associated with lower risks of non-major bleeding (HR 0.73, 95% CI 0.64 to 0.85), whereas rivaroxaban was associated with higher risks of major (HR 1.33, 95% CI 1.15 to 1.55) and non-major (HR 1.29, 95% CI 1.16 to 1.44) bleeding. Conclusions Non-exposure to anticoagulation increases the risks of stroke, myocardial infarction and death in older patients with AF. Clinicians should carefully weigh the risks of discontinuing anticoagulation and provide shared decision-making support to patients, especially when considering deprescription.
Open AccessSafety and effectiveness of anticoagulation therapy in older people with atrial fibrillation during exposed and unexposed treatment periods
Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused in older populations due to concerns about bleeding. This study aimed to compare the safety and effectiveness of anticoagulation during periods of exposure and non-exposure and across different anticoagulants in people with AF aged ≥75 years. Methods Using UK primary care data from the Clinical Practice Research Datalink (2013–2017), a retrospective cohort study was conducted on patients newly prescribed oral anticoagulants (warfarin or direct oral anticoagulants). Exposure to anticoagulation was mapped using prescription data. Cox regression models were used to estimate adjusted HRs for stroke, bleeding, myocardial infarction, and death during periods of exposure and non-exposure and for different anticoagulants. Results Among 20 167 patients (median age 81 years), non-exposure to anticoagulation was associated with higher risks of stroke (HR 3.07, 95% CI 2.39 to 3.93), myocardial infarction (HR 1.85, 95% CI 1.34 to 2.56) and death (HR 2.87, 95% CI 2.63 to 3.12) compared with exposure. Compared with warfarin, apixaban was associated with lower risks of non-major bleeding (HR 0.73, 95% CI 0.64 to 0.85), whereas rivaroxaban was associated with higher risks of major (HR 1.33, 95% CI 1.15 to 1.55) and non-major (HR 1.29, 95% CI 1.16 to 1.44) bleeding. Conclusions Non-exposure to anticoagulation increases the risks of stroke, myocardial infarction and death in older patients with AF. Clinicians should carefully weigh the risks of discontinuing anticoagulation and provide shared decision-making support to patients, especially when considering deprescription.
- Open Access
- 1 January 2024
- Published by SAGE Publications in Gerontology and Geriatric Medicine
- Vol. 10
The Burden of Managing Medicines for Older People With Sensory Impairment: An Ethnographic-Informed Study
Background: Older age is associated with increased prevalence of sensory impairment and use of medicines. Objectives: To explore the daily “medicine journey” of older people with sensory impairment. Methods: The study used ethnographic-informed methods (using audio-, photo- and video-recordings, diary notes and semi-structured interviews with researchers) and involved community-dwelling adults (aged > 65) in Scotland, with visual and/or hearing impairment and using >4 medicines. Data analysis used the constant comparative method. Results: Fourteen older people with sensory impairment participated and used a mean of 11.0 (SD 5.0) medicines (range 5–22). Participants reported difficulties with medicine ordering, obtaining, storage, administration and disposal. They used elaborate strategies to manage their medicines including bespoke storage systems, fixed routines, simple aids, communication, and assistive technologies. Conclusion: Older people with sensory impairment experience substantial burden, challenges and risk with medicines management. Tailored medicine regimens and assistive technologies could provide greater support to older people with sensory impairment.
- 1 January 2024
- Published by SAGE Publications in Gerontology and Geriatric Medicine
- Vol. 10
Open AccessThe Burden of Managing Medicines for Older People With Sensory Impairment: An Ethnographic-Informed Study
Background: Older age is associated with increased prevalence of sensory impairment and use of medicines. Objectives: To explore the daily “medicine journey” of older people with sensory impairment. Methods: The study used ethnographic-informed methods (using audio-, photo- and video-recordings, diary notes and semi-structured interviews with researchers) and involved community-dwelling adults (aged > 65) in Scotland, with visual and/or hearing impairment and using >4 medicines. Data analysis used the constant comparative method. Results: Fourteen older people with sensory impairment participated and used a mean of 11.0 (SD 5.0) medicines (range 5–22). Participants reported difficulties with medicine ordering, obtaining, storage, administration and disposal. They used elaborate strategies to manage their medicines including bespoke storage systems, fixed routines, simple aids, communication, and assistive technologies. Conclusion: Older people with sensory impairment experience substantial burden, challenges and risk with medicines management. Tailored medicine regimens and assistive technologies could provide greater support to older people with sensory impairment.
- Open Access
- 25 November 2023
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 32 (1) , 69-75
Practice pharmacists and their influence on prescribing in UK general practice: a cross-sectional study
Objectives: At the time of the survey, just over 2000 pharmacists were employed in UK general practice. Little is known about their influence on prescribing, and more specifically, the extent of their use of Audit and Feedback (A&F), an evidence-based method for behaviour change. This study aimed to explore pharmacists’ current influence on prescribing in UK general practice. Methods: A cross-sectional, online survey was open to general practice pharmacists in England, Northern Ireland, Scotland, and Wales between 9 September 2021 and 31 October 2021. The survey comprised 36 items, informed by the literature, including multiple choice and free-text questions about pharmacist responsibilities, involvement in prescribing audits (including use of A&F), use of prescribing guidelines, beliefs about influence on prescribing, and access to training and support. Descriptive statistics and frequencies were generated, and parametric analyses were conducted. Key findings: In total, 155 responses were received from pharmacists in diverse practice locations, with a wide range of practice pharmacist experience. The majority (80%, n = 121) conducted prescribing audits, but only 21% (n = 32) reported undertaking A&F. Most respondents (90%, n = 140) used guidelines to inform their work, and 75% (n = 116) would welcome training on influencing prescribing. Pharmacists using A&F were more likely to believe in their ability to influence prescribing and to acknowledge this activity as part of their role. Conclusion: Despite substantial evidence of its effectiveness, A&F is under-used by practice pharmacists. An increased awareness and enablement of practice pharmacists in effective techniques might promote greater evidence-based prescribing in general practice.
- 25 November 2023
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 32 (1) , 69-75
Open AccessPractice pharmacists and their influence on prescribing in UK general practice: a cross-sectional study
Objectives: At the time of the survey, just over 2000 pharmacists were employed in UK general practice. Little is known about their influence on prescribing, and more specifically, the extent of their use of Audit and Feedback (A&F), an evidence-based method for behaviour change. This study aimed to explore pharmacists’ current influence on prescribing in UK general practice. Methods: A cross-sectional, online survey was open to general practice pharmacists in England, Northern Ireland, Scotland, and Wales between 9 September 2021 and 31 October 2021. The survey comprised 36 items, informed by the literature, including multiple choice and free-text questions about pharmacist responsibilities, involvement in prescribing audits (including use of A&F), use of prescribing guidelines, beliefs about influence on prescribing, and access to training and support. Descriptive statistics and frequencies were generated, and parametric analyses were conducted. Key findings: In total, 155 responses were received from pharmacists in diverse practice locations, with a wide range of practice pharmacist experience. The majority (80%, n = 121) conducted prescribing audits, but only 21% (n = 32) reported undertaking A&F. Most respondents (90%, n = 140) used guidelines to inform their work, and 75% (n = 116) would welcome training on influencing prescribing. Pharmacists using A&F were more likely to believe in their ability to influence prescribing and to acknowledge this activity as part of their role. Conclusion: Despite substantial evidence of its effectiveness, A&F is under-used by practice pharmacists. An increased awareness and enablement of practice pharmacists in effective techniques might promote greater evidence-based prescribing in general practice.
- Open Access
Professional stakeholders’ expectations for the future of community pharmacy practice in England: a qualitative study
Objectives: To explore the views of professional stakeholders on the future of community pharmacy services in England. Specific objectives related to expectations of how community pharmacy services will be provided by 2030 and factors that will influence this. Design: Qualitative, using semistructured interviews in person or via telephone/Skype. The topic guide was informed by a recent policy review that used the Walt and Gilson policy framework. Transcripts were analysed using inductive thematic analysis. Setting: England. Participants: External stakeholders were representatives of non-pharmacy organisations, including policy-makers, commissioners and representatives of healthcare professions. Internal stakeholders were community pharmacists or pharmacy organisation representatives. Interviewees were identified using stakeholder mapping Results: In total, 25 interviews were completed (7 external stakeholders and 18 internal stakeholders, of which 10 were community pharmacists). Community pharmacy was recognised as having a key role in expanding health system capacity (‘ …pharmacy is the obvious person to take on those roles… ’), particularly for long-term condition management (eg, adherence, reducing polypharmacy, monitoring), urgent care (eg, minor illnesses) and public health (including mental health). For these contributions to be developed and optimised, greater integration and collaboration with general practices will be needed (‘ …there is no room for isolationism in pharmacy anymore… ’), as well as use of technology in a patient-centred way and full access to health records. These changes will require workforce development together with appropriate commissioning and contractual arrangements. Community pharmacy is currently undervalued (‘ …the complete misunderstanding by senior Government officials is very scary ’) and recent investment in general practice pharmacists rather than community pharmacy was seen as a missed opportunity. Conclusions: Community pharmacy as a sector could and should be developed to increase health service capacity to address its current challenges. Numerous modifications are required from a range of stakeholders to create the environment in which these changes can occur.
Open AccessProfessional stakeholders’ expectations for the future of community pharmacy practice in England: a qualitative study
Objectives: To explore the views of professional stakeholders on the future of community pharmacy services in England. Specific objectives related to expectations of how community pharmacy services will be provided by 2030 and factors that will influence this. Design: Qualitative, using semistructured interviews in person or via telephone/Skype. The topic guide was informed by a recent policy review that used the Walt and Gilson policy framework. Transcripts were analysed using inductive thematic analysis. Setting: England. Participants: External stakeholders were representatives of non-pharmacy organisations, including policy-makers, commissioners and representatives of healthcare professions. Internal stakeholders were community pharmacists or pharmacy organisation representatives. Interviewees were identified using stakeholder mapping Results: In total, 25 interviews were completed (7 external stakeholders and 18 internal stakeholders, of which 10 were community pharmacists). Community pharmacy was recognised as having a key role in expanding health system capacity (‘ …pharmacy is the obvious person to take on those roles… ’), particularly for long-term condition management (eg, adherence, reducing polypharmacy, monitoring), urgent care (eg, minor illnesses) and public health (including mental health). For these contributions to be developed and optimised, greater integration and collaboration with general practices will be needed (‘ …there is no room for isolationism in pharmacy anymore… ’), as well as use of technology in a patient-centred way and full access to health records. These changes will require workforce development together with appropriate commissioning and contractual arrangements. Community pharmacy is currently undervalued (‘ …the complete misunderstanding by senior Government officials is very scary ’) and recent investment in general practice pharmacists rather than community pharmacy was seen as a missed opportunity. Conclusions: Community pharmacy as a sector could and should be developed to increase health service capacity to address its current challenges. Numerous modifications are required from a range of stakeholders to create the environment in which these changes can occur.
- Open Access
- 29 June 2023
- Published by Elsevier in Disability and Health Journal
- Vol. 16 (4) , 101500
Assistive technologies and strategies to support the medication management of individuals with hearing and/or visual impairment: A scoping review
- 29 June 2023
- Published by Elsevier in Disability and Health Journal
- Vol. 16 (4) , 101500
Open AccessAssistive technologies and strategies to support the medication management of individuals with hearing and/or visual impairment: A scoping review